Christopher Ung
AeroLeads people directory · profile

Christopher Ung Email & Phone Number

Chief Scientific Business Officer at CellCarta at CellCarta
Location: Naperville, Illinois, United States 8 work roles 2 schools
1 work email found @cellcarta.com 3 phones found area 630 and 323 LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email c****@cellcarta.com
Direct phone (630) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Chief Scientific Business Officer at CellCarta
Location
Naperville, Illinois, United States

Who is Christopher Ung? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Christopher Ung is listed as Chief Scientific Business Officer at CellCarta at CellCarta, based in Naperville, Illinois, United States. AeroLeads shows a work email signal at cellcarta.com, phone signal with area code 630, 323, and a matched LinkedIn profile for Christopher Ung.

Christopher Ung previously worked as Chief Business Officer at Cellcarta and Advisory Board Member at Stc Biologics. Christopher Ung holds Mba, General Management from Ucla.

Company email context

Email format at CellCarta

This section adds company-level context without repeating Christopher Ung's masked contact details.

{first}.{last}@cellcarta.com
86% confidence

AeroLeads found 1 current-domain work email signal for Christopher Ung. Compare company email patterns before reaching out.

Profile bio

About Christopher Ung

One of the original pioneers in the red-hot personalized medicine field (HercepTest).20 years of experience in companion diagnostics and biomarker development covering all aspects – reagent licensing, development, supply chain management, manufacturing, regulatory applications and global commercialization.Most recently, our lab completed clinical trial testing supporting registration for a BRAF molecular test which received simultaneous FDA approval with a MEK and BRAF small molecule inhibitor. My other PMA experience include development of pharmDx EGFR and clinical testing of a first generation BRAF molecular assay.I offer unique companion diagnostic development perspectives, which are, established through vocations in the diagnostic manufacturing sector, service laboratory, translational biomarker development laboratories and CRO.Since 2009, I have delivered presentations on biomarker-driven oncology development in the US and China. Presentations in China include addresses at the Chinese Society of Clinical Oncology annual meetings.Led the development of four global anatomic pathology laboratories with fully networked digital pathology capabilities – the first in class for a central laboratory.

Listed skills include Oncology, Biotechnology, Clinical Trials, Commercialization, and 17 others.

Current workplace

Christopher Ung's current company

Company context helps verify the profile and gives searchers a useful next step.

CellCarta
Cellcarta
Chief Scientific Business Officer at CellCarta
AeroLeads page
8 roles · 37 years

Christopher Ung work experience

A career timeline built from the work history available for this profile.

Chief Business Officer

Current

Montreal, Quebec, Ca

Jan 2015 - Present

Advisory Board Member

Current
Stc Biologics

STC Biologics, Inc. is a biotechnology company located in Cambridge MA focusing on development of biologic drugs. Our portfolio of drugs includes a MAb biosimilar for Oncology as well as a re-appropriated biologic drug for the treatment of Alzheimer’s.

Jan 2011 - Present

Chief Business Officer

Histogenex

HistoGeneX leads the development of immuno-oncology biomarkers on morphologic and molecular platforms. By combining next generation tissue biomarker technologies with tissue-compatible molecular technologies, we support immuno-oncology therapeutics from research to companion diagnostics.

Jan 2015 - Jan 2015

Coo, Vice President, Business Development & Licensing

Ligacept

An early phase oncology development company, Ligacept established proprietary platform technologies that enable the capture of ligands of oncogenic receptors. Ligacept is positioned to begin Phase I clinical trials.www. ligacept.com

Jan 2011 - Jan 2015

President & Coo

Biomarker Laboratory

We harness emerging biomarker technologies for translational and clinical applications in oncology drug development. We partner with biotech and pharmaceutical companies to develop biomarker assays for exploratory, pharmacodynamics and companion diagnostics. Our lab recently conducted a clinical trial central to a Class III PMA diagnostic test for a BRAF and MEK inhibitor. This is my third start up venture and I have been involved in four oncology PMA-class companion diagnostics.

Jan 2012 - Jan 2014

Vp Strategic Business & Operations, Oncology

Durham, North Carolina, Us

Oncology Development of Targeted Therapies especially for Solid Tumors.Global Anatomic Pathology and Digital Pathology services in support of clinical development of Targeted Therapies and Companion Diagnostics.Established Anatomic Pathology laboratories in China, Scotland and SingaporeOversight of oncology biomarker translational science

Dec 2008 - Jul 2011

Chief Operating Officer

Us

Co-established a biomarker laboratory around IHC and FISH technologies. Created an advocacy program for metastatic colorectal cancer patients centered on standardization of EGFR expression testing. Sold the company to Quintiles in 2008.

Jun 2004 - Dec 2008

Chairman, Pathology Business Group & Director, Strategic Opportunities

Glostrup, Dk

I served as the Chairman of the Pathology Business Group. At Dako I led the commercialization of HercepTest™, a pioneering companion diagnostics and one of the best known personalized medicine tests globally.

1990 - 2004 ~14 yrs
2 education records

Christopher Ung education

Mba, General Management

Ucla

Msc, Chemistry

University Of California, Berkeley
FAQ

Frequently asked questions about Christopher Ung

Quick answers generated from the profile data available on this page.

What company does Christopher Ung work for?

Christopher Ung works for CellCarta.

What is Christopher Ung's role at CellCarta?

Christopher Ung is listed as Chief Scientific Business Officer at CellCarta at CellCarta.

What is Christopher Ung's email address?

AeroLeads has found 1 work email signal at @cellcarta.com for Christopher Ung at CellCarta.

What is Christopher Ung's phone number?

AeroLeads has found 3 phone signal(s) with area code 630, 323 for Christopher Ung at CellCarta.

Where is Christopher Ung based?

Christopher Ung is based in Naperville, Illinois, United States while working with CellCarta.

What companies has Christopher Ung worked for?

Christopher Ung has worked for Cellcarta, Stc Biologics, Histogenex, Ligacept, and Biomarker Laboratory.

How can I contact Christopher Ung?

You can use AeroLeads to view verified contact signals for Christopher Ung at CellCarta, including work email, phone, and LinkedIn data when available.

What schools did Christopher Ung attend?

Christopher Ung holds Mba, General Management from Ucla.

What skills is Christopher Ung known for?

Christopher Ung is listed with skills including Oncology, Biotechnology, Clinical Trials, Commercialization, Clinical Development, Clinical Research, Assay Development, and Fda.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.